APA

Avraham Y., Magen I., Zolotarev O., Vorobiav L., Nachmias A., Pappo O., Ilan Y., Berry E. M. & Ackerman Z. (20081216). 2-Arachidonoylglycerol, an endogenous cannabinoid receptor agonist, in various rat tissues during the evolution of experimental cholestatic liver disease. : Prostaglandins, leukotrienes, and essential fatty acids.

Chicago

Avraham Yosefa, Magen Iddo, Zolotarev Olga, Vorobiav Lia, Nachmias Avital, Pappo Orit, Ilan Yaron, Berry Elliot M and Ackerman Zvi. 20081216. 2-Arachidonoylglycerol, an endogenous cannabinoid receptor agonist, in various rat tissues during the evolution of experimental cholestatic liver disease. : Prostaglandins, leukotrienes, and essential fatty acids.

Harvard

Avraham Y., Magen I., Zolotarev O., Vorobiav L., Nachmias A., Pappo O., Ilan Y., Berry E. M. and Ackerman Z. (20081216). 2-Arachidonoylglycerol, an endogenous cannabinoid receptor agonist, in various rat tissues during the evolution of experimental cholestatic liver disease. : Prostaglandins, leukotrienes, and essential fatty acids.

MLA

Avraham Yosefa, Magen Iddo, Zolotarev Olga, Vorobiav Lia, Nachmias Avital, Pappo Orit, Ilan Yaron, Berry Elliot M and Ackerman Zvi. 2-Arachidonoylglycerol, an endogenous cannabinoid receptor agonist, in various rat tissues during the evolution of experimental cholestatic liver disease. : Prostaglandins, leukotrienes, and essential fatty acids. 20081216.